These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29266632)

  • 21. Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization.
    Ichibori Y; Ohtani T; Nakatani D; Tachibana K; Yamaguchi O; Toda K; Akasaka T; Fukushima N; Sawa Y; Komuro I; Kotani J; Sakata Y
    Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):51-8. PubMed ID: 25976347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of intimal and medial thickening in the human right coronary artery: a study of 17 RCAs.
    Ojha M; Leask RL; Butany J; Johnston KW
    Atherosclerosis; 2001 Sep; 158(1):147-53. PubMed ID: 11500185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravascular sonographic findings after orthotopic heart transplantation: comparison with clinical factors].
    Kerber S; Heinemann-Vechtel O; Schmid C; Janssen F; Block M; Weyand M; Deng M; Scheld HH; Breithardt G
    Herz; 1996 Oct; 21(5):320-9. PubMed ID: 9011541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplant coronary artery disease in pediatric heart transplant recipients.
    Dent CL; Canter CE; Hirsch R; Balzer DT
    J Heart Lung Transplant; 2000 Mar; 19(3):240-8. PubMed ID: 10713248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study.
    Tsutsui H; Ziada KM; Schoenhagen P; Iyisoy A; Magyar WA; Crowe TD; Klingensmith JD; Vince DG; Rincon G; Hobbs RE; Yamagishi M; Nissen SE; Tuzcu EM
    Circulation; 2001 Aug; 104(6):653-7. PubMed ID: 11489770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of optical coherence tomography in children with Kawasaki disease and pediatric heart transplant recipients.
    Harris KC; Manouzi A; Fung AY; De Souza A; Bezerra HG; Potts JE; Hosking MC
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):671-8. PubMed ID: 24874056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphometric analysis of neointimal formation in murine cardiac allografts.
    Armstrong AT; Strauch AR; Starling RC; Sedmak DD; Orosz CG
    Transplantation; 1997 Apr; 63(7):941-7. PubMed ID: 9112344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study).
    Khandhar SJ; Yamamoto H; Teuteberg JJ; Shullo MA; Bezerra HG; Costa MA; Selzer F; Lee JS; Marroquin OC; McNamara DM; Mulukutla SR; Toma C
    J Heart Lung Transplant; 2013 Jun; 32(6):596-602. PubMed ID: 23499356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox.
    Mehra MR; Ventura HO; Uber PA; Scott RL; Park MH
    J Heart Lung Transplant; 2003 Feb; 22(2):118-23. PubMed ID: 12581758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of compensatory enlargement and shrinkage in transplant coronary artery disease. Serial intravascular ultrasound study.
    Lim TT; Liang DH; Botas J; Schroeder JS; Oesterle SN; Yeung AC
    Circulation; 1997 Feb; 95(4):855-9. PubMed ID: 9054742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation.
    Julius BK; Attenhofer Jost CH; Sütsch G; Brunner HP; Kuenzli A; Vogt PR; Turina M; Hess OM; Kiowski W
    Transplantation; 2000 Mar; 69(5):847-53. PubMed ID: 10755538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors.
    Escobar A; Ventura HO; Stapleton DD; Mehra MR; Ramee SR; Collins TJ; Jain SP; Smart FW; White CJ
    Am J Cardiol; 1994 Nov; 74(10):1042-6. PubMed ID: 7977044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of serial intracoronary ultrasound imaging for assessment of progression of intimal proliferation in cardiac transplant recipients.
    Pinto FJ; Chenzbraun A; Botas J; Valantine HA; St Goar FG; Alderman EL; Oesterle SN; Schroeder JS; Popp RL
    Circulation; 1994 Nov; 90(5):2348-55. PubMed ID: 7955193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac allograft vasculopathy: Differences of absolute and relative intimal hyperplasia in children versus adults in optical coherence tomography.
    Orban M; Ulrich S; Dischl D; von Samson-Himmelstjerna P; Schramm R; Tippmann K; Hein-Rothweiler R; Strüven A; Lehner A; Braun D; Hausleiter J; Jakob A; Fischer M; Hagl C; Haas N; Massberg S; Mehilli J; Robert DP
    Int J Cardiol; 2021 Apr; 328():227-234. PubMed ID: 33316256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment and characterization of time-related differences in plaque composition by intravascular ultrasound-derived radiofrequency analysis in heart transplant recipients.
    König A; Kilian E; Sohn HY; Rieber J; Schiele TM; Siebert U; Gothe RM; Reichart B; Klauss V
    J Heart Lung Transplant; 2008 Mar; 27(3):302-9. PubMed ID: 18342753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New developments in the diagnosis and management of cardiac allograft vasculopathy.
    Mehra MR; Ventura HO; Smart FW; Stapleton DD; Collins TJ; Ramee SR; Murgo JP; White CJ
    Tex Heart Inst J; 1995; 22(2):138-44. PubMed ID: 7647597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative 3D Analysis of Coronary Wall Morphology in Heart Transplant Patients: OCT-Assessed Cardiac Allograft Vasculopathy Progression.
    Chen Z; Pazdernik M; Zhang H; Wahle A; Guo Z; Bedanova H; Kautzner J; Melenovsky V; Kovarnik T; Sonka M
    Med Image Anal; 2018 Dec; 50():95-105. PubMed ID: 30253306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts.
    Lu WH; Palatnik K; Fishbein GA; Lai C; Levi DS; Perens G; Alejos J; Kobashigawa J; Fishbein MC
    J Heart Lung Transplant; 2011 Sep; 30(9):1044-50. PubMed ID: 21640617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OCT assessment of allograft vasculopathy in heart transplant recipients.
    Hou J; Lv H; Jia H; Zhang S; Xing L; Liu H; Kong J; Zhang S; Yu B; Jang IK
    JACC Cardiovasc Imaging; 2012 Jun; 5(6):662-3. PubMed ID: 22698538
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison Between Cardiac Allograft Vasculopathy and Native Coronary Atherosclerosis by Optical Coherence Tomography.
    Shan P; Dong L; Maehara A; Nazif TM; Ali ZA; Rabbani LE; Apfelbaum MA; Dalton K; Marboe CC; Mancini DM; Mintz GS; Weisz G
    Am J Cardiol; 2016 Apr; 117(8):1361-8. PubMed ID: 26920081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.